Medicare Enrolled
Dr. Ali Mirhosseini, MD
Cardiovascular Disease · Tracy, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mirhosseini from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mirhosseini?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mirhosseini
Dr. Ali Mirhosseini is a cardiovascular disease specialist in Tracy, CA, with 14 years of NPI registration. Based on federal Medicare data, Dr. Mirhosseini performed 6,427 Medicare services across 3,572 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mirhosseini received a total of $6,596 from 31 pharmaceutical and/or device companies across 307 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mirhosseini is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 14 years in practice
▲ Top 13% volume in CA
$6,596 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,427
Medicare services
Top 13% in CA for cardiovascular disease
3,572
Unique beneficiaries
$91
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~459 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
797 | $51 | $100 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
727 | $91 | $160 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
639 | $39 | $75 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
518 | $97 | $135 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
435 | $130 | $200 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
427 | $40 | $105 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
354 | $37 | $90 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
311 | $11 | $54 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
282 | $151 | $370 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
256 | $42 | $70 |
| Heart muscle strain imaging | 225 | $30 | $65 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
165 | $140 | $258 |
| New patient office visit, complex (60-74 min) | 120 | $151 | $275 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
101 | $19 | $70 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
101 | $729 | $1,100 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
89 | $4 | $12 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
89 | $98 | $170 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 86 | $417 | $525 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
76 | $56 | $212 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
68 | $16 | $30 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
67 | $27 | $56 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
55 | $43 | $175 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
55 | $20 | $238 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
55 | $191 | $570 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
47 | $38 | $175 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
44 | $73 | $115 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle while at rest and during stress. |
43 | $1,250 | $2,300 |
| Programming of multiple lead implantable defibrillator system Adjustment and testing of the settings for an implanted heart device with multiple leads to ensure proper function. |
28 | $46 | $91 |
| Continuous external EKG monitoring, 8-15 days This procedure involves recording heart rhythm continuously using an external EKG device over a period of 8 to 15 days. |
27 | $10 | $23 |
| External EKG monitoring, 8-15 days Continuous external electrocardiogram recording and review over a period of 8 to 15 days to monitor heart rhythm. |
27 | $21 | $40 |
| Aminophylline injection, up to 250 mg Administration of aminophylline medication via injection for a dose of up to 250 mg. |
27 | $7 | $10 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
24 | $357 | $795 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
22 | $13 | $33 |
| Ultrasound of arm and leg arteries A non-invasive imaging test that uses sound waves to examine the blood vessels in the arms and legs. It evaluates blood flow and checks for blockages or other vascular issues. |
15 | $111 | $270 |
| Pacemaker programming, single lead Adjustment and testing of a single-lead pacemaker to ensure it functions correctly. |
14 | $23 | $47 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
11 | $7 | $18 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
6.9% high complexity
12.8% medium
80.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,596
Total received (2018-2024)
Avg $942/year across 7 years
Top 35% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
31
Companies
307
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,506 (98.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$90 (1.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,343
2023
$1,325
2022
$1,792
2021
$1,285
2020
$464
2019
$75
2018
$311
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
E.R. Squibb & Sons, L.L.C.
$189
Merck Sharp & Dohme LLC
$174
AstraZeneca Pharmaceuticals LP
$156
Bayer Healthcare Pharmaceuticals Inc.
$98
CVRx, Inc.
$92
PFIZER INC.
$90
Kiniksa Pharmaceuticals International, plc
$77
Boehringer Ingelheim Pharmaceuticals, Inc.
$76
Amgen Inc.
$75
Novartis Pharmaceuticals Corporation
$68
Lilly USA, LLC
$40
Lexicon Pharmaceuticals, Inc.
$34
Alnylam Pharmaceuticals Inc.
$34
Janssen Pharmaceuticals, Inc
$33
Actelion Pharmaceuticals US, Inc.
$29
United Therapeutics Corporation
$23
ATRICURE, INC.
$20
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$18
Esperion Therapeutics, Inc.
$18
Top 3 companies account for 38.6% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Pharmaceuticals, Inc
$843
AstraZeneca Pharmaceuticals LP
$720
Merck Sharp & Dohme LLC
$625
Boehringer Ingelheim Pharmaceuticals, Inc.
$469
Novartis Pharmaceuticals Corporation
$369
Amgen Inc.
$358
E.R. Squibb & Sons, L.L.C.
$308
Bayer HealthCare Pharmaceuticals Inc.
$303
PFIZER INC.
$275
Alnylam Pharmaceuticals Inc.
$248
Abbott Laboratories
$238
ATRICURE, INC.
$217
BIOTRONIK INC.
$212
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$203
Novo Nordisk Inc
$195
Bayer Healthcare Pharmaceuticals Inc.
$192
SANOFI-AVENTIS U.S. LLC
$131
CVRx, Inc.
$92
Merck Sharp & Dohme Corporation
$88
Kiniksa Pharmaceuticals International, plc
$77
Lexicon Pharmaceuticals, Inc.
$67
United Therapeutics Corporation
$59
Amarin Pharma Inc.
$59
Esperion Therapeutics, Inc.
$58
Lilly USA, LLC
$53
BOSTON SCIENTIFIC CORPORATION
$31
Actelion Pharmaceuticals US, Inc.
$29
Regeneron Healthcare Solutions, Inc.
$27
Kiniksa Pharmaceuticals, Ltd.
$23
Xeris Pharmaceuticals, Inc.
$14
Amryt Pharma Holdings Ltd
$13
Top 3 companies account for 33.2% of all-time payments
Associated products mentioned in payments ›
AMVUTTRA · ANDEXXA · ATRICLIP LAA EXCLUSION SYSTEM · Adempas · Arcalyst · BRILINTA · Barostim Neo System · CAMZYOS · CardioMEMS HF System · Confirm Rx · Corlanor · ELIQUIS · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · Edora 8 DR-T · FARXIGA · GVOKE PFS · Inpefa · JARDIANCE · JUXTAPID · Kerendia · LEQVIO · LifeVest · MOUNJARO · MULTAQ · NEXLETOL · ONPATTRO · Ozempic · PRALUENT ALIROCUMAB INJECTION · Rebinyn · Repatha · Rybelsus · TYVASO · UPTRAVI · VERQUVO · VYNDAQEL · Vascepa · WAINUA · WATCHMAN · WINREVAIR · XARELTO · XIGDUO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
49
Per 100K population
6.2
County median income
$88,531
Nearest hospital
SUTTER TRACY COMMUNITY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mirhosseini is a clinical cardiology specialist, with above-average Medicare volume (top 13% in CA), with low-engagement industry engagement.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mirhosseini experienced with chronic care management, first 20 min/month?
Based on Medicare claims data, Dr. Mirhosseini performed 797 chronic care management, first 20 min/month services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mirhosseini receive payments from pharmaceutical companies?
Yes. Dr. Mirhosseini received a total of $6,596 from 31 companies across 307 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mirhosseini's costs compare to other cardiologists in Tracy?
Dr. Mirhosseini's average Medicare payment per service is $91. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mirhosseini) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Tracy
Browse cardiologists in Tracy ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Merck Sharp & Dohme LLC Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology